Prosciento, Inc.

Chula Vista, California 91911

3 studies enrolling now · 24 studies all time

What they study most

COVID-19, Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Health Adult Subjects, Healthy, Hyperoxaluria, Hypertension, Hypoglycemia, Hypothyroidism, Insulin Hypoglycemia

Studies at this site

• A Study to Evaluate Safety, Tolerability and Pharmacokinetics of Orally Administered TIX100 in Healthy Subjects — Recruiting now
• A Single Bolus, 12-hour Euglycemic Clamp Study of the Safety, Pharmacokinetics (PK) and Glucodynamics (GD) of Intraperitoneal (IP) Portal Insulin U-500 — Recruiting now
• A Phase 1 Study to Evaluate Safety, Tolerability and Pharmacokinetics of TIX100 in Healthy Subjects — Recruiting now
• A Study to Evaluate the Efficacy and Safety of Once-Weekly MET097 in Adults With Obesity or Overweight and T2DM — Completed
• Study to Evaluate HM15275 in Obese or Overweight Subjects Without Diabetes Mellitus — Running, not enrolling
• A Study of FT 4101 in Overweight/Obese Participants With Non-alcoholic Steatohepatitis — Stopped early
• Study of XP-8121 For the Treatment of Adult Subjects With Hypothyroidism — Completed
• A Phase 1 Study to Assess HM15275 in Healthy and Obese Subjects. — Completed
• A Phase 1b Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of JNJ-64565111 in Participants With Type 2 Diabetes Mellitus — Completed
• A Study Evaluating the Safety, Tolerability, and Pharmacodynamic Effects of GLY-200 in Type 2 Diabetic Patients — Completed
• A Study of Multiple Doses of HM15211(Efocipegtrutide) in Obese Subjects With NAFLD — Completed
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of K-757 in Healthy Overweight/Obese Volunteers — Completed
• A Study of BMN 255 in Participants With Non-Alcoholic Fatty Liver Disease And Hyperoxaluria — Withdrawn before enrolling
• Phase 1b/2a Study of GSBR-1290 in Adult Overweight or Obese Healthy Subjects and Subjects With Type 2 Diabetes Mellitus — Completed
• A Study of LY3532226 in Participants With Type 1 Diabetes Mellitus — Completed
• Study to Evaluate the Efficacy of IN STI-9199 in Treating Symptomatic COVID-19 in Outpatient Adults and Adolescents — Withdrawn before enrolling
• AT247, NovoLog® and Fiasp® Administered Via Continuous Subcutaneous Infusion in Glucose Clamp Study — Completed
• A Comparison of Postprandial Glucose After a MMTT, and the Metabolic Effects of Insulin Withdrawal in a Crossover Study in Subjects With Type 1 Diabetes — Completed
• Multiple Ascending Dose (MAD) Study of IMT-002 in HLA-DQ8-positive Type 1 Diabetes — Completed
• Trial to Confirm the Clinical Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in Subjects With T1DM — Completed
• A Study To Assess Pharmacodynamics, Safety And Tolerability Of PF-05221304 And PF-06865571 Co-Administered For 6 Weeks In Adults With Non-Alcoholic Fatty Liver Disease. — Completed
• Trial of IW-1973, A Stimulator of Soluble Guanylate Cyclase (sGC) in Patients With Stable Type 2 Diabetes and Hypertension — Completed
• G-Pen™ Compared to Lilly Glucagon for Hypoglycemia Rescue in Adults With Type 1 Diabetes — Completed
• Safety and Efficacy of G-Pen Compared to Lilly Glucagon for Hypoglycemia Rescue in Adult Type 1 Diabetics — Completed